NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 312 filers reported holding NOVAVAX INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $30,000 | -96.3% | 575 | -94.8% | 0.00% | -100.0% |
Q1 2022 | $821,000 | -50.3% | 11,146 | +4.5% | 0.01% | -44.4% |
Q4 2021 | $1,651,000 | -66.9% | 10,671 | -55.6% | 0.01% | -66.7% |
Q3 2021 | $4,987,000 | -3.0% | 24,057 | -0.6% | 0.03% | -15.6% |
Q2 2021 | $5,139,000 | +18933.3% | 24,199 | +16032.7% | 0.03% | – |
Q1 2021 | $27,000 | +58.8% | 150 | 0.0% | 0.00% | – |
Q4 2020 | $17,000 | +6.2% | 150 | 0.0% | 0.00% | – |
Q3 2020 | $16,000 | -74.6% | 150 | -80.0% | 0.00% | -100.0% |
Q2 2020 | $63,000 | +530.0% | 750 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |